The epidemiological characteristics, clinical manifestations, and outcomes of individuals diagnosed with COVID-19 infection at Al-Salama, Al-Ameria Hospital, during the period of April to August 2022.
DOI:
https://doi.org/10.46966/msjar.v4i2.128Keywords:
COVID-19, quarantine, co morbidity, and case fatality rateAbstract
Background: The majority of individuals who contract COVID-19, a disease caused by a novel coronavirus, are capable of recuperating at home without requiring hospitalization. However, elderly individuals and those with pre-existing medical conditions, such as heart disease, diabetes, chronic lung disease, or cancer, are at a greater risk of developing severe illnesses and may require hospitalization. The objective of this study: is to provide a detailed account of the epidemiology, clinical manifestations, and outcomes of COVID-19 patients who were admitted to Al-Salama Hospital, Al-Ameria, Baghdad, Iraq. Method: In this study, a retrospective analysis was conducted to investigate cases of COVID-19 infection that were admitted to Al-Salama Hospital, located in Al-Ameria, of Al-Karkh Health Directorate in Baghdad. Demographic data, clinical presentation, and outcomes were extracted using a specialized form. Results: The study included 101 cases admitted to Al-Salama Hospital from April to August 2022, out of which 87 were confirmed positive for COVID-19 through PCR testing while 14 were not tested. Among those who were tested, 5 cases tested negative and were discharged, while 9 cases tested positive, resulting in a total of 96 diagnosed cases of COVID-19.The duration of hospitalization was determined based on the severity of the illness. Moderate-severe cases (85/96) were discharged improved after a hospital stay of 3-7 days, while severe-critical cases (11/96) resulted in fatalities. The primary causes of death were respiratory failure and sepsis, and the patients stayed in the hospital for 8-21 days. Of the cases studied, 35/96 had been vaccinated against COVID-19. Out of the 11 deceased patients, 9 had a history of vaccination, while 26/85 of the discharged patients had been immunized. Males accounted for 56% of the cases, and the age range of 60-69 years had the highest number of male patients. Most female patients were in the age group of 80-95 years. The distribution of hospital admissions followed a trend similar to the 3rd and 5th waves of the epidemic that hit Iraq in July 2021 and 2022, respectively. Respiratory symptoms were the most common clinical presentation (74%), followed by gastrointestinal symptoms (12%), headache (8%), and chest pain (7%). Comorbidities were prevalent, with hypertension (43%), diabetes mellitus (32%), and cardiovascular disease (15%) being the most common. Conclusions: In conclusion, the findings of this study may have implications not only for Al-Salama Hospital Al-Ameria in Iraq but also for other countries with comparable epidemiological and clinical characteristics and disease outcomes during the pandemic.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Fawzi Hashim Atshan, Ibtisam Faraj Hasan

This work is licensed under a Creative Commons Attribution 4.0 International License.
In submitting the manuscript to the Medical Science Journal for Advance Research, the authors certify that:
- They are authorized by their co-authors to enter into these arrangements.
- The work described has not been formally published before, except in the form of an abstract or as part of a published lecture, review, thesis, or overlay journal.
- That it is not under consideration for publication elsewhere,
- The publication has been approved by the author(s) and by responsible authorities – tacitly or explicitly – of the institutes where the work has been carried out.
- They secure the right to reproduce any material that has already been published or copyrighted elsewhere.
- They agree to the following license and copyright agreement.
License and Copyright Agreement
Authors who publish with Medical Science Journal for Advance Research agree to the following terms:
- Authors retain copyright and grant the Medical Science Journal for Advance Research right of first publication with the work simultaneously licensed under Creative Commons Attribution License (CC BY 4.0) that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors can enter into separate, additional contractual arrangements for the non-exclusive distribution of the Medical Science Journal for Advance Research published version of the work (e.g., post it to an institutional repository or edit it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) before and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.


















